Boehringer Ingelheim's Pipeline Update Unveils Novel Investigational Compounds Heralding The Company's Entry Into Type 2 Diabetes Boehringer Ingelheim announced that patients and physicians may have several innovative Type 2 Diabetes treatment alternatives available in the coming years. At its Second International Research & Development Press Conference, Boehringer Ingelheim unveiled a pipeline of unique oral anti-diabetic compounds in phase II and III, establishing the company in the Type 2 Diabetes arena.
Source: www.medicalnewstoday.com'Invisibility' Of Women Who Have Had Abortions Diminishes Rights, Opinion Piece Says As public attitudes become more tolerant toward gay rights and "being gay is losing its stigma," having an abortion is "being more deeply stigmatized," Boston Globe columnist Ellen Goodman writes in an opinion piece. Goodman writes that the issue was a topic of discussion among attendees at a recent
Source: www.medicalnewstoday.comGrassley, Kohl Seek Information About Money Going From Medical Device Makers To Doctors, USA Senators Chuck Grassley and Herb Kohl are continuing their campaign to shed light on financial relationships between the pharmaceutical and medical device industries and medical doctors. Today the senators sent letters asking for detailed information about industry dollars going to research physicians affiliated with Columbia University and to the Cardiovascular Research Foundation.
Source: www.medicalnewstoday.comNational Petition For Preemies Launched By Mothers Mothers are casting their votes for
healthy babies and asking all Americans to join them in signing the March of Dimes 2008 Petition for Preemies. They're putting public officials - and all Americans - on notice that it's time to focus on the growing problem of premature birth, the leading cause of newborn death.
Source: www.medicalnewstoday.com
# posted by Network @ 6:00 AM
